MDxHealth Statistics
Total Valuation
MDxHealth has a market cap or net worth of $90.58 million. The enterprise value is $105.69 million.
Important Dates
The next confirmed earnings date is Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MDxHealth has 49.50 million shares outstanding. The number of shares has increased by 26.82% in one year.
| Current Share Class | 49.50M |
| Shares Outstanding | 49.50M |
| Shares Change (YoY) | +26.82% |
| Shares Change (QoQ) | +74.69% |
| Owned by Insiders (%) | 9.21% |
| Owned by Institutions (%) | 27.00% |
| Float | 35.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.68 |
| Forward PS | 0.85 |
| PB Ratio | 6.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 4.05.
| Current Ratio | 1.57 |
| Quick Ratio | 1.44 |
| Debt / Equity | 4.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.24 |
Financial Efficiency
Return on equity (ROE) is -345.31% and return on invested capital (ROIC) is -25.05%.
| Return on Equity (ROE) | -345.31% |
| Return on Assets (ROA) | -10.79% |
| Return on Invested Capital (ROIC) | -25.05% |
| Return on Capital Employed (ROCE) | -21.56% |
| Revenue Per Employee | $288,619 |
| Profits Per Employee | -$122,016 |
| Employee Count | 312 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 10.50 |
Taxes
In the past 12 months, MDxHealth has paid $382,000 in taxes.
| Income Tax | 382,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.94% in the last 52 weeks. The beta is -494,746.42, so MDxHealth's price volatility has been lower than the market average.
| Beta (5Y) | -494,746.42 |
| 52-Week Price Change | -33.94% |
| 50-Day Moving Average | 1.60 |
| 200-Day Moving Average | 2.07 |
| Relative Strength Index (RSI) | 63.23 |
| Average Volume (20 Days) | 59,277 |
Short Selling Information
| Short Interest | 74,488 |
| Short Previous Month | 27,344 |
| Short % of Shares Out | 0.18% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.41 |
Income Statement
In the last 12 months, MDxHealth had revenue of $90.05 million and -$38.07 million in losses. Loss per share was -$1.16.
| Revenue | 90.05M |
| Gross Profit | 55.14M |
| Operating Income | -24.72M |
| Pretax Income | -39.90M |
| Net Income | -38.07M |
| EBITDA | -18.96M |
| EBIT | -24.72M |
| Loss Per Share | -$1.16 |
Full Income StatementBalance Sheet
The company has $46.93 million in cash and $60.06 million in debt, giving a net cash position of -$13.13 million or -$0.27 per share.
| Cash & Cash Equivalents | 46.93M |
| Total Debt | 60.06M |
| Net Cash | -13.13M |
| Net Cash Per Share | -$0.27 |
| Equity (Book Value) | 14.84M |
| Book Value Per Share | 0.30 |
| Working Capital | 24.23M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$18.53 million and capital expenditures -$1.19 million, giving a free cash flow of -$19.72 million.
| Operating Cash Flow | -18.53M |
| Capital Expenditures | -1.19M |
| Free Cash Flow | -19.72M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
Gross margin is 61.23%, with operating and profit margins of -27.45% and -42.28%.
| Gross Margin | 61.23% |
| Operating Margin | -27.45% |
| Pretax Margin | -41.85% |
| Profit Margin | -42.28% |
| EBITDA Margin | -21.05% |
| EBIT Margin | -27.45% |
| FCF Margin | n/a |
Dividends & Yields
MDxHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.82% |
| Shareholder Yield | -26.82% |
| Earnings Yield | -41.13% |
| FCF Yield | -21.30% |
Analyst Forecast
The average price target for MDxHealth is $6.00, which is 227.87% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 227.87% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 19.65% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on November 14, 2023. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
MDxHealth has an Altman Z-Score of -2.69 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.69 |
| Piotroski F-Score | 2 |